Roche rules out merger talk
October 18, 2013Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger
Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …
SCM Pharma appoints new director
October 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing SCM Pharma, simon bellamy
Contract development and manufacturing organisation SCM Pharma has expanded its commercial management team with the appointment of a new director. …
Astellas gets NICE nod
October 18, 2013Sales and Marketing Cancer, NHS, NICE, Xtandi
Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …
Travel ban ambiguity for GSK ‘s former China boss
October 17, 2013Sales and Marketing China, GSK, bribery, reilly
GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …
Quest starts selling BRCA tests
October 17, 2013Sales and Marketing BRCA, Myriad, Quest, jolie
Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …
GCI Health expands with new London office
October 17, 2013Medical Communications GCI Health, agency, comms
Healthcare communications agency GCI Health has officially opened its London office. The expansion, in response to the agency’s growing global …
GAVI begins roll-out of cheap HPV vaccine
October 17, 2013Sales and Marketing GAVI, HPV, Vaccine
For the first time women in parts of the world with the highest cervical cancer death rate will be able …
Director appointed for MediCity
October 17, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing browning, medicity
Former chief executive of Philips Healthcare and Consumer Lifestyle David Browning has been appointed director of MediCity. The new Nottingham-based …
Phase III boost for alirocumab
October 17, 2013Sales and Marketing LDL, Regeneron, alirocumab
Sanofi and Regeneron Pharmaceuticals are celebrating some upbeat data from their investigational treatment alirocumab, which has proved adept at tackling …
Patients should ‘top up’ NHS costs
October 16, 2013Sales and Marketing Dixon, England, NHS, NICE, top up
A leading doctor believes that NHS patients must produce top up payments for treatments for non-life threatening conditions. Speaking at …
Rare disease fund scrapped by NHS England
October 16, 2013Research and Development, Sales and Marketing NHS England, fund, rare diseases
NHS England has pulled the plug on a £50 million fund to advance innovation in the investigation and treatment of …
Former FDA commissioner joins J&J
October 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, J&J, JJ
Johnson & Johnson has announced that ex-FDA commissioner Mark McClellan has been appointed to its Board of directors. Dr McClellan …
Johnson & Johnson posts strong Q3 results
October 16, 2013Sales and Marketing J&J, JJ, Q3, Velcade, results
Johnson & Johnson has posted a strong set of financials for the third quarter as new products from its pharma …
Novartis launches Facebook ‘retina app’
October 15, 2013Medical Communications AMD, Bayer, Lucentis, Novartis, set your sights
Novartis, the world’s biggest eye-care drugmaker, has launched a new Facebook retina app to raise awareness of retinal disease. The …
AstraZeneca pays $460m for cancer specialists
October 15, 2013Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen
AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …
Billions spent on European cancer care
October 15, 2013Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer
A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …
Price cut not enough for Pixuvri
October 15, 2013Sales and Marketing Cell Therapeutics, NICE, pixuvri
NICE is still saying no to Cell Therapeutics’ lymphoma drug Pixuvri, despite the firm offering a discount on the treatment’s …
Roche poised to get even bigger in biomanufacturing
October 15, 2013Manufacturing and Production Jobs, Merck, Roche, cuts
Roche plans to invest a massive 800 million Swiss francs ($882m) over the next five years to increase manufacturing capacity …
String of appointments to BIA Board
October 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, appointments
The BioIndustry Association has appointed Kevin Cox, Donna Hackett, Jane Osbourn, Stephen Taylor, Patrick Verheyen and Tim Watts to its …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
